Gilead Makes Generic HIV Drug Plan, Advocates Urge Expansion
By Dan McKay · October 3, 2024, 9:28 PM EDT
Gilead Sciences Inc. this week announced a plan to allow six drugmakers to produce generic lenacapavir to help combat the HIV pandemic in 120 lower-income countries, an initiative that won praise...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login